Organizational Growth Planning
Closing Investment Deals
Medical devices (Class II, III)
Point of Care Diagnostics
Medical Imaging (MRI, ultrasound,
Machine learning for Business Strategy
Joel Liederman is an accomplished senior executive with more than 45 years of high technology company leadership, domestic & international business development expertise, in high technology industries, including having spent the last 30 years as a venture capital investor and start-up “company builder”. His educational background includes a Bachelor’s Degree in Electrical Engineering from McGill University and an MBA (specialization in international marketing and finance) from Concordia University. Mr. Liederman’s responsibilities have included roles as CEO of a next generation mammography machine company and CEO of a solar materials company – both of which Joel helped spin out of the academic organization where the company’s core technology was developed to the point that each company was able to secure its first round of serious venture capital investment funding.
Previously, Joel was Vice President, Physical Sciences at MaRS Innovation - (now Toronto Innovation Acceleration Partners), a commercialization engine and venture capital investor for the organization’s 15 members (major universities and teaching hospitals in the Toronto area). Prior to that, he held roles as a senior engineering design manager, project engineering manager for two CANDU 6 nuclear power plants, general manager of an engineering design office, VP of marketing, sales and business development at General Electric, Atomic Energy of Canada Ltd., Alcatel and Spar Aerospace. Joel spent several years as a venture capital investor at Primaxis Technology Ventures.
Joel has a proven track record in supporting early stage companies with a unique mix of "company builder" strengths in corporate governance, fundraising, project management, marketing, business development, client relationship development and management, strategic planning, communications and problem solving across multiple sectors including medical devices, enterprise software, electronics, and advanced materials. He currently serves on the board of Addem Labs and IRegained.